Cite
HARVARD Citation
Bolli, G. et al. (2021). Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial. Diabetes, obesity & metabolism. 23 (7), pp. 1588-1593. [Online].